Saturday, 8 May 2021

DCGI gives nod to anti-COVID drug developed by DRDO for emergency use

The Drugs Controller General of India (DCGI) on Saturday (May 8, 2021) approved drug 2-deoxy-D-glucose (2-DG) which is developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), DRDO in collaboration with Dr Reddy’s Lab.
http://dlvr.it/RzKMBS

No comments:

Post a Comment